Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Platelet counts and liver enzymes after bariatric surgery.

Johansson HE, Haenni A, Zethelius B.

J Obes. 2013;2013:567984. doi: 10.1155/2013/567984. Epub 2013 Feb 20.

2.

Roux-en-Y divided gastric bypass results in the same weight loss as duodenal switch for morbid obesity.

Deveney CW, MacCabee D, Marlink K, Welker K, Davis J, McConnell DB.

Am J Surg. 2004 May;187(5):655-9.

PMID:
15135686
3.

Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass.

Skroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F.

Obes Surg. 2002 Aug;12(4):551-8.

PMID:
12194550
5.

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Tai CM, Huang CK, Hwang JC, Chiang H, Chang CY, Lee CT, Yu ML, Lin JT.

Obes Surg. 2012 Jul;22(7):1016-21. doi: 10.1007/s11695-011-0579-7.

PMID:
22161114
6.

Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial.

Hedberg J, Sundbom M.

Surg Obes Relat Dis. 2012 May-Jun;8(3):338-43. doi: 10.1016/j.soard.2012.01.014. Epub 2012 Feb 1.

PMID:
22425057
7.

Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery.

Johansson HE, Haenni A, Zethelius B.

J Obes. 2011;2011:273105. doi: 10.1155/2011/273105. Epub 2011 Dec 26.

8.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
9.

Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients.

Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ.

Obes Surg. 2005 Jun-Jul;15(6):858-63.

PMID:
15978159
10.

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, Raverdy V, Leteurtre E, Dharancy S, Louvet A, Romon M, Duhamel A, Pattou F, Mathurin P.

Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25.

PMID:
25917783
11.

Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients.

Topart P, Becouarn G, Ritz P.

Surg Obes Relat Dis. 2013 Jul-Aug;9(4):526-30. doi: 10.1016/j.soard.2012.02.006. Epub 2012 Mar 3.

PMID:
22498360
12.

Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.

Ricci G, Bersani G, Rossi A, Pigò F, De Fabritiis G, Alvisi V.

Obes Surg. 2008 Nov;18(11):1438-42. doi: 10.1007/s11695-008-9487-x. Epub 2008 Mar 28.

PMID:
18369681
14.

Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.

Folini L, Veronelli A, Benetti A, Pozzato C, Cappelletti M, Masci E, Micheletto G, Pontiroli AE.

Acta Diabetol. 2014;51(3):361-8. doi: 10.1007/s00592-013-0516-4. Epub 2013 Oct 2.

PMID:
24085682
15.

Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)).

Skroubis G, Kouri N, Mead N, Kalfarentzos F.

Obes Surg. 2014 Feb;24(2):197-204. doi: 10.1007/s11695-013-1081-1.

PMID:
24105406
16.

The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus.

Frühbeck G, Diez-Caballero A, Gil MJ, Montero I, Gómez-Ambrosi J, Salvador J, Cienfuegos JA.

Obes Surg. 2004 May;14(5):606-12.

PMID:
15186626
17.

Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.

Keshishian A, Zahriya K, Willes EB.

Obes Surg. 2005 Nov-Dec;15(10):1418-23.

PMID:
16354521
18.

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ.

J Gastroenterol Hepatol. 2007 Apr;22(4):510-4.

PMID:
17376042
19.

Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery.

Pimentel SK, Strobel R, Gonçalves CG, Sakamoto DG, Ivano FH, Coelho JC.

Arq Gastroenterol. 2010 Apr-Jun;47(2):170-3.

20.

Comparison of weight loss and body composition changes with four surgical procedures.

Strain GW, Gagner M, Pomp A, Dakin G, Inabnet WB, Hsieh J, Heacock L, Christos P.

Surg Obes Relat Dis. 2009 Sep-Oct;5(5):582-7. doi: 10.1016/j.soard.2009.04.001. Epub 2009 Apr 14.

PMID:
19560983
Items per page

Supplemental Content

Write to the Help Desk